Monoclonal antibody treatment may be administered to vulnerable patients at home

Abstract

Hospital pharmacy teams could be involved in the aseptic preparation of neutralising monoclonal antibodies (nMABs), which would be given to patients in their homes as part of new NHS treatment services for COVID-19. The monoclonal antibody treatment could be available to patients at high risk of severe disease and mortality — including ‘clinically extremely vulnerable’ […]